Cargando…

Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy

BACKGROUND: Candida parapsilosis was the most common species causing candidemia in the 2010 China Hospital Invasive Fungal Surveillance Net (CHIF-NET) database. Compared to Candida albicans, the description of azole resistance and mechanisms in C. parapsilosis is very limited. We report a patient wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Li, Xiao, Meng, Watts, Matthew R., Wang, He, Fan, Xin, Kong, Fanrong, Xu, Ying-Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539859/ https://www.ncbi.nlm.nih.gov/pubmed/26282840 http://dx.doi.org/10.1186/s12879-015-1086-6

Ejemplares similares

Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit
por: Pinhati, Henrique Marconi Sampaio, et al.
Publicado: (2016)

Candida parapsilosis Candidemia Resistance Patterns and Treatment Outcomes: An Opportunity for Antifungal Stewardship
por: Fong, Gary, et al.
Publicado: (2017)

A Brazilian Inter-Hospital Candidemia Outbreak Caused by Fluconazole-Resistant Candida parapsilosis in the COVID-19 Era
por: Thomaz, Danilo Y., et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic on the Clinical Profile of Candidemia and the Incidence of Fungemia Due to Fluconazole-Resistant Candida parapsilosis
por: Ramos-Martínez, Antonio, et al.
Publicado: (2022)

Increase in Candida Parapsilosis Candidemia in Cancer Patients
por: Sun, Mingyue, et al.
Publicado: (2019)

Systemic Candida parapsilosis Infection Model in Immunosuppressed ICR Mice and Assessing the Antifungal Efficiency of Fluconazole
por: Wu, Yu'e, et al.
Publicado: (2015)

Candida parapsilosis keratitis treated successfully with topical and oral fluconazole
por: Li, Pei-Hsuan, et al.
Publicado: (2016)

Antifungal Susceptibility Analysis of Clinical Isolates of Candida parapsilosis in Iran
por: LOTFALI, Ensieh, et al.
Publicado: (2016)

Determinants of fluconazole resistance and the efficacy of fluconazole and milbemycin oxim combination against Candida parapsilosis clinical isolates from Brazil and Turkey
por: Daneshnia, Farnaz, et al.
Publicado: (2022)

Clonal Candidemia Outbreak by Candida parapsilosis Carrying Y132F in Turkey: Evolution of a Persisting Challenge
por: Arastehfar, Amir, et al.
Publicado: (2021)

Epidemiology and risk factors of candidemia due to Candida parapsilosis in an intensive care unit
por: Zuo, Xiao-shu, et al.
Publicado: (2021)

P027 Early warning bells: emergence of fluconazole resistance in Candida parapsilosis
por: Ajapuje, Preeti
Publicado: (2022)

Fluconazole-resistant Candida parapsilosis: A new emerging threat in the fungi arena
por: Escribano, Pilar, et al.
Publicado: (2022)

357. Risk Factors and Antifungal Susceptibility Pattern of Candida parapsilosis Candidemia: A Single centre Observation study from Central India.
por: Garg, Rahul, et al.
Publicado: (2022)

Candidemia among Hospitalized Pediatric Patients Caused by Several Clonal Lineages of Candida parapsilosis
por: Hare, Rasmus Krøger, et al.
Publicado: (2022)

Molecular Characterization of Candida parapsilosis by Microsatellite Typing and Emergence of Clonal Antifungal Drug Resistant Strains in a Multicenter Surveillance in China
por: Zhang, Li, et al.
Publicado: (2020)

Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates
por: Denardi, Laura Bedin, et al.
Publicado: (2015)

146. antifungal Susceptibility Patterns of candida Parapsilosis Bloodstream Isolates in the US, 2008–2018
por: Tesini, Brenda L, et al.
Publicado: (2020)

Synergistic Antifungal Activity of Chitosan with Fluconazole against Candida albicans, Candida tropicalis, and Fluconazole-Resistant Strains
por: Lo, Wei-Hsuan, et al.
Publicado: (2020)

Fluconazole-Resistant Candida parapsilosis Bloodstream Isolates with Y132F Mutation in ERG11 Gene, South Korea
por: Choi, Yong Jun, et al.
Publicado: (2018)

2885. Increased incidence of fluconazole-resistant Candida parapsilosis bloodstream infections in Atlanta, Georgia 2021
por: Witt, Lucy S, et al.
Publicado: (2023)

Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China
por: Ning, Yating, et al.
Publicado: (2022)

Determinants of fluconazole resistance and echinocandin tolerance in C. parapsilosis isolates causing a large clonal candidemia outbreak among COVID-19 patients in a Brazilian ICU
por: Daneshnia, Farnaz, et al.
Publicado: (2022)

Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients
por: Wu, Ping-Feng, et al.
Publicado: (2017)

Species Distribution of Candidemia and Their Susceptibility in a Single Japanese University Hospital: Prior Micafungin Use Affects the Appearance of Candida parapsilosis and Elevation of Micafungin MICs in Non-parapsilosis Candida Species
por: Sakamoto, Yasutaka, et al.
Publicado: (2021)

Eucalyptal D Enhances the Antifungal Effect of Fluconazole on Fluconazole-Resistant Candida albicans by Competitively Inhibiting Efflux Pump
por: Xu, Jiali, et al.
Publicado: (2019)

Aneuploidy enables cross-tolerance to unrelated antifungal drugs in Candida parapsilosis
por: Sun, Liu-liu, et al.
Publicado: (2023)

Candida parapsilosis sensu stricto Antifungal Resistance Mechanisms and Associated Epidemiology
por: Franconi, Iacopo, et al.
Publicado: (2023)

Combination antifungal therapy for treatment of Candida parapsilosis prosthetic valve endocarditis and utility of T2Candida Panel®: A case series
por: Ahuja, Tania, et al.
Publicado: (2019)

The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia
por: Bouza, Emilio, et al.
Publicado: (2014)

Microsatellite genotyping of clinical Candida parapsilosis isolates
por: Badali, Hamid, et al.
Publicado: (2017)

Regulation of ERG3, ERG6, and ERG11 Genes in Antifungal-Resistant isolates of Candida parapsilosis
por: Lotfali, Ensieh, et al.
Publicado: (2017)

Global Emergence of Resistance to Fluconazole and Voriconazole in Candida parapsilosis in Tertiary Hospitals in Spain During the COVID-19 Pandemic
por: Trevijano-Contador, Nuria, et al.
Publicado: (2022)

Characterization of the transcriptional response of Candida parapsilosis to the antifungal peptide MAF-1A
por: Cheng, Rong, et al.
Publicado: (2020)

Antifungal Effect and Inhibition of the Virulence Mechanism of D-Limonene against Candida parapsilosis
por: Leite-Andrade, Melyna Chaves, et al.
Publicado: (2022)

Synergistic Antifungal Activity of Synthetic Peptides and Antifungal Drugs against Candida albicans and C. parapsilosis Biofilms
por: Bezerra, Leandro P., et al.
Publicado: (2022)

Profile susceptibility to fluconazole and voriconazole antifungals by species of Candida albicans isolated from urine culture
por: Wiebusch, Laura, et al.
Publicado: (2014)

Antifungal activity of curcumin-silver nanoparticles against fluconazole-resistant clinical isolates of Candida species
por: Paul, Sony, et al.
Publicado: (2018)

Antifungal Susceptibility of Oral Candida Isolates from Mother-Infant Dyads to Nystatin, Fluconazole, and Caspofungin
por: Alkhars, Naemah, et al.
Publicado: (2023)

Cm-p5 Peptide Dimers Inhibit Biofilms of Candida albicans Clinical Isolates, C. parapsilosis and Fluconazole-Resistant Mutants of C. auris
por: Amann, Valerie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v910frgnnd5n0jdis4861mijqb